Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|23|3691-3698

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.23, 2014-12, pp. : 3691-3698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer

By  

Oncology, Vol. 90, Iss. 3, 2016-02 ,pp. : 127-135

Karger

Access to resources Recommend Favorite

Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 25, Iss. 9, 2016-09 ,pp. : 1106-1112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Body fatness at a young age, body fatness gain and risk of breast cancer: systematic review and meta‐analysis of cohort studies

By  

OBESITY REVIEWS, Vol. 19, Iss. 2, 2018-02 ,pp. : 254-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome

By Li Lin  

Wiener klinische Wochenschrift, Vol. 122, Iss. 17-18, 2010-09 ,pp. : 519-524

Springer Publishing Company

Access to resources Recommend Favorite

Relationships among attention function, exercise, and body mass index: a comparison between young breast cancer survivors and acquaintance controls

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 3, 2015-03 ,pp. : 325-332

John Wiley & Sons Inc

Access to resources Recommend Favorite